全球生物医学加温解冻设备市场规模、份额、成长分析、按产品（手动、自动）、按样本（血液製品、卵子/胚胎）-产业预测 2024-2031

Global Biomedical Warming and Thawing Devices Market Size, Share, Growth Analysis, By Product(Manual, Automatic), By Sample(Blood Products, Ovum/Embryo) - Industry Forecast 2024-2031

出版日期: 2024年05月02日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年，全球生物医学加温解冻设备市场规模为3.75亿美元，预计将从2023年的4.0785亿美元成长到2031年的7.9846亿美元，预测期间（2024-2031年）复合年增长率为8.76亿美元，预测期内（2024-2031年）复合年增长率为8.76亿美元，预测期（2024-2031） % 。

近年来，全球生物医学加温和解冻设备市场见证了显着的成长和发展。这些设备透过促进冷冻生物样本的受控解冻和升温，在各种生物医学和生命科学应用中发挥至关重要的作用，包括细胞培养、体外受精 (IVF)、药物发现和生物库。市场成长的一个重要推动因素是对再生医学和生物银行研究的需求不断增长。随着再生医学领域的不断扩大，对用于移植的冷冻保存细胞和组织的精确、高效解冻和加温的需求日益增长。储存各种生物样本的生物样本库也依赖这些设备在检索过程中保持样本的完整性。此外，COVID-19 大流行凸显了这些设备在疫苗、血液製品和诊断试剂储存和运输中的重要性，进一步促进了其市场扩张。技术进步促进了创新自动化加温和解冻设备的发展，这些设备可提高解冻过程的精度和速度。这些设备还具有用户友好的介面和可自订的设置，使它们对研究人员和临床医生更具吸引力。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 拉丁美洲其他地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- MEA 的其余部分

竞争格局

前 5 名玩家比较
2023 年关键参与者的市场定位
主要市场参与者所采取的策略
最佳制胜策略
近期市集活动
主要公司市占率 (%), 2023

主要公司简介

Helmer Scientific, Inc. (USA)
Thermo Fisher Scientific Inc. (USA)
Sarstedt AG & Co. KG (Germany)
Boekel Scientific (USA)
Barkey GmbH & Co. KG (Germany)
BioCision, LLC (USA)
Cardinal Health, Inc. (USA)
Sartorius AG (Germany)
Biocool (France)
Helago-Celsis (Germany)
CytoTherm (USA)
Cole-Parmer Instrument Company, LLC (USA)
Cyagen Biosciences (USA)
Geno Technology, Inc. (USA)
BrainBits LLC (USA)
ADVANCED BIOLOGICAL MARKETING (USA)
Hamilton Bonaduz AG (Switzerland)
Deltalab SL (Spain)
Boehringer Ingelheim (Germany)
Arlington Scientific, Inc. (USA)
Hamilton Company (USA)
GE Healthcare (USA)
ThawSTAR (USA)
3M (USA)
Thomas Scientific (USA)

简介目录

Product Code: SQMIG35B2178

Global biomedical warming and thawing devices market size was valued at USD 375 million in 2022 and is poised to grow from USD 407.85 million in 2023 to USD 798.46 million by 2031, growing at a CAGR of 8.76% in the forecast period (2024-2031).

The global biomedical warming and thawing devices market has witnessed remarkable growth and evolution in recent years. These devices play a crucial role in various biomedical and life science applications, including cell culture, in vitro fertilization (IVF), drug discovery, and biobanking, by facilitating controlled thawing and warming of frozen biological samples. A significant driver of market growth is the increasing demand for regenerative medicine and biobanking research. With the expanding field of regenerative medicine, there is a growing need for precise and efficient thawing and warming of cryopreserved cells and tissues for transplantation. Biobanks, which store a wide array of biological samples, also rely on these devices to maintain sample integrity during retrieval. Additionally, the COVID-19 pandemic has underscored the importance of these devices in the storage and transportation of vaccines, blood products, and diagnostic reagents, further contributing to their market expansion. Technological advancements have led to the development of innovative and automated warming and thawing devices that offer enhanced precision and speed in the thawing process. These devices also feature user-friendly interfaces and customizable settings, making them more appealing to researchers and clinicians.

Top-down and bottom-up approaches were used to estimate and validate the size of the global biomedical warming and thawing devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biomedical Warming and Thawing Devices Market Segmental Analysis

The global biomedical warming and thawing devices market is segmented based on product, sample, end consumer, and place. By Product, the market is segmented into manual, and automatic. By sample, the market is segmented into Blood products, ovum/embryo, semen, and others. By end person, the market is segmented into hospitals, research laboratories, pharmaceutical industry, blood banks and transfusion centers, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Biomedical Warming and Thawing Devices Market

The increasing demand for biopharmaceutical products, including vaccines, antibodies, and cell-based therapies, has heightened the requirement for efficient and specialized warming and thawing devices. These devices play a crucial role in the safe and effective storage and processing of biopharmaceuticals, thus driving market growth.

Restraints in the Global Biomedical Warming and Thawing Devices Market

Biomedical warming and thawing devices can come with a hefty price tag for both purchase and installation. The substantial initial capital investment needed for these devices can pose a significant barrier, particularly for smaller healthcare facilities, research laboratories, and developing nations. This cost factor has the potential to limit market adoption.

Market Trends of the Global Biomedical Warming and Thawing Devices Market

One notable trend in the biomedical warming and thawing devices market is the increasing adoption of automated thawing solutions. Traditional thawing methods, such as manual water bath thawing, can be time-consuming and pose the risk of sample contamination. Automated thawing devices offer precision and efficiency in thawing various types of samples, including blood products, cellular therapies, and frozen tissues. These devices often feature advanced temperature control and monitoring capabilities, ensuring the preservation of sample integrity. The demand for automated thawing solutions is expected to continue rising as laboratories and healthcare facilities seek to streamline their sample preparation processes and reduce the risk of human errors.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Biomedical Warming and Thawing Devices Market By Product

Market Overview
Manual
Automatic

Global Biomedical Warming and Thawing Devices Market By Sample

Market Overview
Blood Products
Ovum/Embryo
Semen
and Others

Global Biomedical Warming and Thawing Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Helmer Scientific, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sarstedt AG & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boekel Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Barkey GmbH & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioCision, LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biocool (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Helago-Celsis (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CytoTherm (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cole-Parmer Instrument Company, LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cyagen Biosciences (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Geno Technology, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BrainBits LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ADVANCED BIOLOGICAL MARKETING (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hamilton Bonaduz AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Deltalab S.L. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arlington Scientific, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hamilton Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ThawSTAR (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
3M (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thomas Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments